Status:

COMPLETED

Risk Stratification of Non ST Elevation ACS With Computed Tomographic Angiography (REACT)

Lead Sponsor:

Ottawa Heart Institute Research Corporation

Conditions:

Acute Coronary Syndrome

Non-ST-Elevation Myocardial Infarction

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this project is to examine the effectiveness of computed tomographic angiography (CTA) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS). People who are hospitalized ...

Eligibility Criteria

Inclusion

  • High risk ACS
  • Angina \[accelerating pattern or prolonged episode (\> 20 minutes) or recurrent episode at rest or with minimal effort within preceding 24 hours\]; and (13)
  • Elevated Troponin - T (≥0.1 ug/L) or ECG changes consistent with ischemia \[ST depression ≥ 0.1 mV, transient ST segment elevation ≥ 0.1 mV (\< 20 minutes)\]) (11;13)
  • Planned conventional invasive coronary angiography

Exclusion

  • Age \< 18 years or lack of consent
  • Renal Insufficiency (GFR \< 60 ml/min)
  • Allergy to contrast agent
  • Refractory angina requiring urgent/emergent coronary angiography (as per treating physician)
  • Contraindication to radiation exposure (e.g. pregnancy)
  • Uncontrolled HR
  • Previous CABG or PCI/Stent
  • Atrial fibrillation, frequent atrial or ventricular ectopy (\> 1 / minute)
  • Unable to perform 20 second breath-hold

Key Trial Info

Start Date :

September 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2010

Estimated Enrollment :

107 Patients enrolled

Trial Details

Trial ID

NCT00449826

Start Date

September 1 2006

End Date

December 1 2010

Last Update

January 26 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Ottawa Heart Institute

Ottawa, Ontario, Canada, K1Y 4W7